1.97
price down icon4.83%   -0.10
after-market After Hours: 1.97
loading
Nkarta Inc stock is traded at $1.97, with a volume of 802.59K. It is down -4.83% in the last 24 hours and up +0.51% over the past month. Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
See More
Previous Close:
$2.07
Open:
$2.05
24h Volume:
802.59K
Relative Volume:
1.52
Market Cap:
$139.92M
Revenue:
-
Net Income/Loss:
$-117.50M
P/E Ratio:
-0.8208
EPS:
-2.4
Net Cash Flow:
$-114.31M
1W Performance:
-12.83%
1M Performance:
+0.51%
6M Performance:
+8.24%
1Y Performance:
-64.76%
1-Day Range:
Value
$1.96
$2.05
1-Week Range:
Value
$1.96
$2.28
52-Week Range:
Value
$1.31
$5.94

Nkarta Inc Stock (NKTX) Company Profile

Name
Name
Nkarta Inc
Name
Phone
(925) 407-1049
Name
Address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
Employee
157
Name
Twitter
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
NKTX's Discussions on Twitter

Compare NKTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NKTX
Nkarta Inc
1.97 143.47M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
394.53 99.62B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
465.89 61.52B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.00 58.91B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
756.38 46.69B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
324.34 34.54B 3.81B -644.79M -669.77M -6.24

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-25 Downgrade William Blair Outperform → Mkt Perform
Oct-09-24 Initiated Rodman & Renshaw Buy
Aug-14-24 Upgrade Raymond James Outperform → Strong Buy
Mar-22-24 Downgrade Raymond James Strong Buy → Outperform
Dec-22-22 Downgrade Oppenheimer Outperform → Perform
Oct-10-22 Initiated Canaccord Genuity Buy
Jul-28-22 Initiated Needham Buy
Jul-18-22 Initiated SVB Leerink Outperform
Mar-11-22 Initiated Raymond James Outperform
Mar-08-22 Initiated H.C. Wainwright Buy
Jan-06-22 Initiated William Blair Outperform
Nov-18-21 Initiated SMBC Nikko Outperform
Jul-16-21 Initiated Oppenheimer Outperform
Aug-04-20 Initiated Cowen Outperform
Aug-04-20 Initiated Evercore ISI Outperform
Aug-04-20 Initiated Mizuho Buy
Aug-04-20 Initiated Stifel Buy
View All

Nkarta Inc Stock (NKTX) Latest News

pulisher
Sep 12, 2025

How to integrate Nkarta Inc. into portfolio analysis tools2025 Price Momentum & Scalable Portfolio Growth Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Multi factor analysis applied to Nkarta Inc.Market Weekly Review & Weekly High Return Forecasts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Volatility clustering patterns for Nkarta Inc.Portfolio Performance Report & Consistent Return Investment Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What high frequency data says about Nkarta Inc.Quarterly Market Review & Daily Price Action Insights - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Analyzing Nkarta Inc. with risk reward ratio chartsJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is Nkarta Inc. still worth holding after the dipJuly 2025 Price Swings & Advanced Technical Analysis Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Can trapped investors hope for a rebound in Nkarta Inc.July 2025 Macro Moves & Free Daily Entry Point Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Live market analysis of Nkarta Inc.Trade Risk Assessment & Precise Entry and Exit Recommendations - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Candlestick signals on Nkarta Inc. stock todayPortfolio Gains Summary & Low Risk High Win Rate Picks - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Advanced analytics toolkit walkthrough for Nkarta Inc.July 2025 Fed Impact & Daily Market Momentum Tracking - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using economic indicators to assess Nkarta Inc. potentialWeekly Profit Report & Community Verified Trade Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Real time pattern detection on Nkarta Inc. stockSell Signal & High Return Stock Watch Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Signal strength of Nkarta Inc. stock in tech scanners2025 Market Sentiment & Breakout Confirmation Trade Signals - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

Alyeska Investment Group L.P. Increases Stock Holdings in Nkarta, Inc. $NKTX - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Nuveen LLC Purchases Shares of 140,113 Nkarta, Inc. $NKTX - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Is Nkarta Inc. building a consolidation baseLong Setup & AI Forecasted Entry/Exit Points - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Nkarta Inc. recovery potential after sell offEarnings Risk Report & Risk Controlled Swing Trade Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Will Nkarta Inc. see short term momentum2025 Fundamental Recap & Capital Protection Trade Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Predicting Nkarta Inc. trend using moving averagesGDP Growth & Consistent Profit Trade Alerts - Newser

Sep 11, 2025
pulisher
Sep 10, 2025

Custom strategy builders for tracking Nkarta Inc.2025 Performance Recap & Reliable Intraday Trade Plans - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

How Nkarta Inc. stock performs during market volatilityJuly 2025 Pullbacks & Weekly High Return Opportunities - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Using R and stats models for Nkarta Inc. forecastingMarket Risk Report & Long-Term Growth Stock Strategies - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Custom watchlist performance reports with Nkarta Inc.July 2025 Gainers & Weekly Sector Rotation Insights - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Nkarta Inc.’s volatility index tracking explainedJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

how to build a dashboard for nkarta inc. stockEarnings Growth Summary & Stock Portfolio Risk Control - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Can technical indicators confirm Nkarta Inc.’s reversal2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Using data tools to time your Nkarta Inc. exitWeekly Trade Report & Capital Efficient Trading Techniques - Newser

Sep 10, 2025
pulisher
Sep 09, 2025

Applying chart zones and confluence areas to Nkarta Inc.July 2025 Spike Watch & Accurate Intraday Trade Tips - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Is Nkarta Inc. stock a buy or sellJuly 2025 EndofMonth & Community Trade Idea Sharing - Lancaster City Council

Sep 09, 2025
pulisher
Sep 09, 2025

How to build a dashboard for Nkarta Inc. stockShare Buyback & Real-Time Volume Spike Alerts - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Leading vs lagging indicators on Nkarta Inc. performancePortfolio Return Report & High Yield Equity Trading Tips - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Applying Elliott Wave Theory to Nkarta Inc.July 2025 Short Interest & Accurate Buy Signal Alerts - Newser

Sep 09, 2025

Nkarta Inc Stock (NKTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Cap:     |  Volume (24h):